SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products Inc. (Second Sight) today announced that the Argus II Retinal Prosthesis System was implanted in patients with Retinitis Pigmentosa (RP) in the U.S. for the first time since it was approved by the U.S. Food and Drug Administration (FDA) last year.
Help employers find you! Check out all the jobs and post your resume.
